Physician profile
Manuel Pedroso
NPI 1851464077
$2,080.90
in general payments reported to CMS, 2019-2025
12 companies · $235 in 2025
The $235 reported for 2025 was more than what 78% of Adolescent Medicine (Pediatrics) providers received nationally (typical 2025 total: $99.31).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $505 · 2020: $130 · 2021: $244 · 2022: $135 · 2023: $264 · 2024: $568 · 2025: $235.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,044 · Long Term Medical Supply Or Device Loan: $23.04.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,043.77 |
| Long Term Medical Supply Or Device Loan | $23.04 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $442.17 | 2019-2025 | |
| Glaxosmithkline, LLC. | $381.27 | 2019-2024 | Pediarix, Bexsero, Rotarix |
| Cranial Technologies, INC | $307.83 | 2019-2025 | Doc Band |
| Sanofi Pasteur INC. | $272.34 | 2021-2025 | |
| Genentech USA, INC. | $183.78 | 2019 | |
| Verrica Pharmaceuticals INC. | $181.64 | 2024 | Ycanth |
| Merck Sharp & Dohme LLC | $178.45 | 2023-2025 | Vaxneuvance, Gardasil 9, Vaxelis |
| Phadia US INC. | $54.66 | 2022-2025 | Immunocap |
| Sobi, INC | $31.91 | 2021 | |
| Baxter Healthcare | $23.04 | 2025 | Hillrom - Spot Vision Screener |
| Hologic Sales and Service, LLC | $19.65 | 2023 | Coolseal Generator |
| Tms Neurohealth Centers INC. | $4.16 | 2025 | Tms Neurohealth Centers INC. |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Manuel Pedroso listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.